Additionally, mRNA expression of YTHDF2 turned out to be associated either positively (lymphocyte percentage and C3 levels) or negatively (neutrophil–lymphocyte ratio) with several clinical SLE features. This evidence concerns the gene YTHDF2 and systemic lupus erythematosus.